154 related articles for article (PubMed ID: 32894579)
1. Optical coherence tomography detects retinal changes in hereditary cerebral amyloid angiopathy.
van Etten ES; de Boer I; Steenmeijer SR; Al-Nofal M; Wermer MJH; Notting IC; Terwindt GM
Eur J Neurol; 2020 Dec; 27(12):2635-2640. PubMed ID: 32894579
[TBL] [Abstract][Full Text] [Related]
2. Multiple Approaches to Diffusion Magnetic Resonance Imaging in Hereditary Cerebral Amyloid Angiopathy Mutation Carriers.
Schouten TM; de Vos F; van Rooden S; Bouts MJRJ; van Opstal AM; Feis RA; Terwindt GM; Wermer MJH; van Buchem MA; Greenberg SM; de Rooij M; Rombouts SARB; van der Grond J
J Am Heart Assoc; 2019 Feb; 8(3):e011288. PubMed ID: 30717612
[TBL] [Abstract][Full Text] [Related]
3. Cerebrovascular function in presymptomatic and symptomatic individuals with hereditary cerebral amyloid angiopathy: a case-control study.
van Opstal AM; van Rooden S; van Harten T; Ghariq E; Labadie G; Fotiadis P; Gurol ME; Terwindt GM; Wermer MJH; van Buchem MA; Greenberg SM; van der Grond J
Lancet Neurol; 2017 Feb; 16(2):115-122. PubMed ID: 27989553
[TBL] [Abstract][Full Text] [Related]
4. Spectral Domain Optical Coherence Tomography in Retinal Vasculopathy With Cerebral Leukoencephalopathy and Systemic Manifestations: A Monogenic Small Vessel Disease.
de Boer I; Steenmeijer SR; Pelzer N; Al-Nofal M; Dijkman G; Notting IC; Terwindt GM
J Neuroophthalmol; 2022 Mar; 42(1):e130-e136. PubMed ID: 34334759
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Progression of Magnetic Resonance Imaging Markers and Cognition in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
van Dijk SE; van der Grond J; Lak J; van den Berg-Huysmans A; Labadie G; Terwindt GM; Wermer MJH; Gurol ME; van Buchem MA; Greenberg SM; van Rooden S
Stroke; 2022 Jun; 53(6):2006-2015. PubMed ID: 35360926
[TBL] [Abstract][Full Text] [Related]
6. Cerebellar hemorrhages in patients with Dutch-type hereditary cerebral amyloid angiopathy.
Voigt S; de Kruijff PC; Koemans EA; Rasing I; van Etten ES; Terwindt GM; van Osch M; van Buchem MA; van Walderveen M; Wermer M
Int J Stroke; 2022 Jul; 17(6):637-644. PubMed ID: 34427476
[TBL] [Abstract][Full Text] [Related]
7. Brain Deep Medullary Veins on 7T MRI in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
van Harten TW; Heijmans A; van Rooden S; Wermer MJH; van Osch MJP; Kuijf HJ; van Veluw SJ; Greenberg SM; van Buchem MA; van der Grond J; van Walderveen MAA
J Alzheimers Dis; 2022; 90(1):381-388. PubMed ID: 36120778
[TBL] [Abstract][Full Text] [Related]
8. Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.
Fotiadis P; van Rooden S; van der Grond J; Schultz A; Martinez-Ramirez S; Auriel E; Reijmer Y; van Opstal AM; Ayres A; Schwab KM; ; Hedden T; Rosand J; Viswanathan A; Wermer M; Terwindt G; Sperling RA; Polimeni JR; Johnson KA; van Buchem MA; Greenberg SM; Gurol ME
Lancet Neurol; 2016 Jul; 15(8):811-819. PubMed ID: 27180034
[TBL] [Abstract][Full Text] [Related]
9. OCT in Alzheimer's disease: thinning of the RNFL and superior hemiretina.
Cunha JP; Proença R; Dias-Santos A; Almeida R; Águas H; Alves M; Papoila AL; Louro C; Castanheira-Dinis A
Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1827-1835. PubMed ID: 28643042
[TBL] [Abstract][Full Text] [Related]
10. Presymptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy-Related Blood Metabolite Alterations.
Chatterjee P; Fagan AM; Xiong C; McKay M; Bhatnagar A; Wu Y; Singh AK; Taddei K; Martins I; Gardener SL; Molloy MP; Multhaup G; Masters CL; Schofield PR; Benzinger TLS; Morris JC; Bateman RJ; Greenberg SM; Wermer MJH; van Buchem MA; Sohrabi HR; Martins RN;
J Alzheimers Dis; 2021; 79(2):895-903. PubMed ID: 33361604
[TBL] [Abstract][Full Text] [Related]
11. β-Amyloid in CSF: Biomarker for preclinical cerebral amyloid angiopathy.
van Etten ES; Verbeek MM; van der Grond J; Zielman R; van Rooden S; van Zwet EW; van Opstal AM; Haan J; Greenberg SM; van Buchem MA; Wermer MJ; Terwindt GM
Neurology; 2017 Jan; 88(2):169-176. PubMed ID: 27903811
[TBL] [Abstract][Full Text] [Related]
12. Migraine With Aura as Early Disease Marker in Hereditary Dutch-Type Cerebral Amyloid Angiopathy.
Koemans EA; Voigt S; Rasing I; van Etten ES; van Zwet EW; van Walderveen MAA; Wermer MJH; Terwindt GM
Stroke; 2020 Apr; 51(4):1094-1099. PubMed ID: 32114932
[TBL] [Abstract][Full Text] [Related]
13. Occipital Cortical Calcifications in Cerebral Amyloid Angiopathy.
Rasing I; Voigt S; Koemans EA; van Zwet E; de Kruijff PC; van Harten TW; van Etten ES; van Rooden S; van der Weerd L; van Buchem MA; van Osch MJP; Greenberg SM; van Walderveen MAA; Terwindt GM; Wermer MJH
Stroke; 2021 May; 52(5):1851-1855. PubMed ID: 33813865
[TBL] [Abstract][Full Text] [Related]
14. Innovative Magnetic Resonance Imaging Markers of Hereditary Cerebral Amyloid Angiopathy at 7 Tesla.
Koemans EA; van Etten ES; van Opstal AM; Labadie G; Terwindt GM; Wermer MJH; Webb AG; Gurol EM; Greenberg SM; van Buchem MA; van der Grond J; van Rooden S
Stroke; 2018 Jun; 49(6):1518-1520. PubMed ID: 29695466
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of the Boston criteria version 2.0 in Dutch-type hereditary cerebral amyloid angiopathy.
van der Zwet R; Koemans EA; Voigt S; van Dort R; Rasing I; Kaushik K; van Harten TW; Schipper MR; Terwindt GM; van Osch M; van Walderveen M; van Etten ES; Wermer M
Int J Stroke; 2024 Mar; ():17474930241239801. PubMed ID: 38444323
[TBL] [Abstract][Full Text] [Related]
16. Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy.
de Kort AM; Kuiperij HB; Jäkel L; Kersten I; Rasing I; van Etten ES; van Rooden S; van Osch MJP; Wermer MJH; Terwindt GM; Schreuder FHBM; Klijn CJM; Verbeek MM
Alzheimers Res Ther; 2023 Jun; 15(1):102. PubMed ID: 37270536
[TBL] [Abstract][Full Text] [Related]
17. Temporal Ordering of Biomarkers in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
Koemans EA; Rasing I; Voigt S; van Harten TW; van der Zwet RGJ; Kaushik K; Schipper MR; van der Weerd N; van Zwet EW; van Etten ES; van Osch MJP; Kuiperij B; Verbeek MM; Terwindt GM; Greenberg SM; van Walderveen MAA; Wermer MJH
Stroke; 2024 Apr; 55(4):954-962. PubMed ID: 38445479
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric symptoms with focus on apathy and irritability in sporadic and hereditary cerebral amyloid angiopathy.
Kaushik K; de Kort AM; van Dort R; van der Zwet RGJ; Siegerink B; Voigt S; van Zwet EW; van der Plas MC; Koemans EA; Rasing I; Kessels RPC; Middelkoop HAM; Schreuder FHBM; Klijn CJM; Verbeek MM; Terwindt GM; van Etten ES; Wermer MJH
Alzheimers Res Ther; 2024 Apr; 16(1):74. PubMed ID: 38582898
[TBL] [Abstract][Full Text] [Related]
19. Decreased ratios of matrix metalloproteinases to tissue-type inhibitors in cerebrospinal fluid in sporadic and hereditary cerebral amyloid angiopathy.
Vervuurt M; de Kort AM; Jäkel L; Kersten I; Abdo WF; Schreuder FHBM; Rasing I; Terwindt GM; Wermer MJH; Greenberg SM; Klijn CJM; Kuiperij HB; Verbeek MM
Alzheimers Res Ther; 2023 Jan; 15(1):26. PubMed ID: 36717932
[TBL] [Abstract][Full Text] [Related]
20. Predictors of retinal atrophy in multiple sclerosis: A longitudinal study using spectral domain optical coherence tomography with segmentation analysis.
Behbehani R; Adnan H; Al-Hassan AA; Al-Salahat A; Alroughani R
Mult Scler Relat Disord; 2018 Apr; 21():56-62. PubMed ID: 29459346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
